Loubna Chadli is a Clinical Biomarker Strategy leader at Servier, specializing in immunoinflammation and neurosciences. They bring over a decade of experience in drug discovery and development, having previously served as a project leader and biomarker strategy leader in various organizations, including Charles River Laboratories and Galapagos. Loubna completed a Ph.D. in Cell and Molecular Biology from CEA, where they investigated the TGF-β pathway's role in keratinocyte stem cell regulation. They hold multiple degrees with high honors from prestigious institutions, including Ecole normale supérieure and Université Denis Diderot.
This person is not in the org chart
This person is not in any teams
This person is not in any offices